Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors

被引:56
作者
Paoletti, E
Cassottana, P
Bellino, D
Specchia, C
Messa, P
Cannella, G
机构
[1] Univ Genoa, Sez Biostat, Dipartimento Sci Salute, Div Nefrol Dialisi & Trapianto, Genoa, Italy
[2] Azienda Osped San Martino, Div Cardiol, Genoa, Italy
关键词
left ventricular (LV) geometry; left ventricular hypertrophy (LVH); angiotensin-converting enzyme (ACE) inhibitors; hemodialysis (HD); cardiovascular events;
D O I
10.1053/ajkd.2002.35680
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. In addition to the absolute magnitude of left ventricular (LV) mass (LVM), the geometric pattern of the left ventricle might help explain the different tendency toward LV hypertrophy (LVH) regression seen under effective therapy in chronic hemodialysis patients. Methods: Forty-five hemodialyzed uremic subjects, 17 patients with concentric LVH and 28 patients with eccentric LVH, were followed up with yearly echocardiography over 3 years while on monotherapy with angiotensin-converting enzyme (ACE) inhibitors. Predialysis blood pressure (BP) and percentage of interdialytic weight gain recorded during the month the echocardiographic study was performed were retrieved and averaged. Any adverse cardiovascular events occurring during the 3-year follow-up period also were recorded. Results: Significant regression of LVH (P = 0.0028) was observed in the group as a whole during the 3 years on ACE-inhibitor therapy, mainly accounted for by a reduction in pulse pressure (PP; r = 0.45; P = 0.0017). After subgrouping patients according to LV geometry, an LVM reduction was observed only in the 17 patients with concentric LVH (P = 0.0003), whereas no difference was detected in subjects with eccentric LVH despite the same degree of 1313 reduction and hemoglobin level and Kt/V increases in both groups. Moreover, a greater incidence of cardiovascular events was observed in patients with eccentric LVH than in those with concentric LVH during the 3-year follow-up period. Conclusion: The most important finding of this study is that eccentric LVH seems to be less responsive to ACE-inhibitor treatment and is associated with a greater incidence of adverse cardiovascular events compared with concentric LVH. Furthermore, the decrease in PP appears to be the main predictor of LVH regression in chronic hemodialysis patients on ACE-inhibitor therapy. (C) 2002 by the National Kidney Foundation, Inc.
引用
收藏
页码:728 / 736
页数:9
相关论文
共 34 条
[1]   Prediction of hypertension in chronic hemodialysis patients [J].
Agarwal, R ;
Lewis, RR .
KIDNEY INTERNATIONAL, 2001, 60 (05) :1982-1989
[2]   Impact of pulse pressure on degree of cardiac hypertrophy in patients with chronic uraemia [J].
Brahimi, M ;
Dahan, M ;
Dabiré, H ;
Levy, BI .
JOURNAL OF HYPERTENSION, 2000, 18 (11) :1645-1650
[3]   PRESSURE-INDUCED AND VOLUME-INDUCED LEFT-VENTRICULAR HYPERTROPHIES ARE ASSOCIATED WITH DISTINCT MYOCYTE PHENOTYPES AND DIFFERENTIAL INDUCTION OF PEPTIDE GROWTH-FACTOR MESSENGER-RNAS [J].
CALDERONE, A ;
TAKAHASHI, N ;
IZZO, NJ ;
THAIK, CM ;
COLUCCI, WS .
CIRCULATION, 1995, 92 (09) :2385-2390
[4]   Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy [J].
Cannella, G ;
Paoletti, E ;
Barocci, S ;
Massarino, F ;
Delfino, R ;
Ravera, G ;
Di Maio, G ;
Nocera, A ;
Patrone, P ;
Rolla, D .
KIDNEY INTERNATIONAL, 1998, 54 (02) :618-626
[5]   REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY FOLLOWING RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT OF ANEMIC DIALYZED UREMIC PATIENTS [J].
CANNELLA, G ;
LACANNA, G ;
SANDRINI, M ;
GAGGIOTTI, M ;
NORDIO, G ;
MOVILLI, E ;
MOMBELLONI, S ;
VISIOLI, O ;
MAIORCA, R .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (01) :31-37
[6]   Clues for understanding the pathogenesis of left ventricular hypertrophy in chronic uremia [J].
Cannella, G ;
Paoletti, E .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1998, 21 (07) :378-383
[7]   REGRESSION OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE DIALYZED UREMIC PATIENTS ON LONG-TERM ANTIHYPERTENSIVE THERAPY [J].
CANNELLA, G ;
PAOLETTI, E ;
DELFINO, R ;
PELOSO, G ;
MOLINARI, S ;
TRAVERSO, GB .
KIDNEY INTERNATIONAL, 1993, 44 (04) :881-886
[8]   Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects [J].
Cannella, G ;
Paoletti, E ;
Delfino, R ;
Peloso, G ;
Rolla, D ;
Molinari, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (05) :659-664
[9]  
CANNELLA G, 1988, CLIN NEPHROL, V30, P187
[10]   Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients [J].
Cannella, G ;
Paoletti, E ;
Ravera, G ;
Cassottana, P ;
Araghi, P ;
Mulas, D ;
Peloso, G ;
Delfino, R ;
Messa, P .
KIDNEY INTERNATIONAL, 2000, 58 (01) :260-268